2023Q1营收归零,继续亏损,目前看不到投资价值。查看全文
美股律师郝俊波2021-06-09 17:18
$AcelRx制药(ACRX)$ 【AcelRx Pharmaceuticals Inc(ACRX)证券诉讼信息 】
AcelRx Pharmaceuticals Inc(ACRX)因证券欺诈案已经于近日被投资者诉至法院。在目前的诉讼中投资者指控该公司在2020年3月17日至2021年2月12日期间就公司的业务、运营及合规问题进行虚假陈述,未向投资者披露以下重大不...查看全文
$AcelRx制药(ACRX)$ 8-K - Current report Filed: 2019-06-25 AccNo: 0001437749-19-012706 Size: 63 KBItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 5.07: Submission of Matters to a Vote of Security HoldersItem 9.01: Financial Statements an...
$AcelRx制药(ACRX)$ 内部交易: 2019-06-05,CEO,Angotti Vincent J. ,买入,5000普通股, $2.31
$AcelRx制药(ACRX)$ 8-K - Current report Filed: 2019-06-03 AccNo: 0001437749-19-011209 Size: 462 KBItem 1.01: Entry into a Material Definitive AgreementItem 1.02: Termination of a Material Definitive AgreementItem 2.03: Creation of a Direct Financial Obligation or an Obligatio...
$AcelRx制药(ACRX)$ DEF 14A - Other definitive proxy statements Filed: 2019-05-14 AccNo: 0001437749-19-009718 Size: 1 MB 网页链接
$AcelRx制药(ACRX)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2019-05-14 AccNo: 0001437749-19-009720 Size: 582 KB 网页链接
$AcelRx制药(ACRX)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-05-09 AccNo: 0001437749-19-009191 Size: 4 MB 网页链接
$AcelRx制药(ACRX)$ 8-K - Current report Filed: 2019-05-08 AccNo: 0001437749-19-009104 Size: 125 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$AcelRx制药(ACRX)$ PRE 14A - Other preliminary proxy statements Filed: 2019-05-03 AccNo: 0001437749-19-008725 Size: 1 MB 网页链接
$AcelRx制药(ACRX)$ 10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2019-04-30 AccNo: 0001437749-19-008205 Size: 1 MB 网页链接